Quantifying Hydrogen-Bonding Interactions in the Self-Assembly of Photoresponsive Azobenzene Amphiphiles at the Air-Water Interface.

Amphiphilic azobenzene molecules offer ample scope to design functional supramolecular systems in an aqueous medium that can be controlled by light. Despite their widespread applications in photopharmacology and optoelectronics, the self-assembly pathways and energy landscapes of these systems are not well understood. Here, we report combined molecular dynamics (MD) simulation and surface manometry studies on a specially designed alkylated, meta-substituted azobenzene derivative to quantify the hydrogen-bonding interactions in the self-assembled monolayers of its photoisomers.

Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs.

During the last twenty years, organic fluorination chemistry established itself as an important tool to get a biologically active compound. This belief can be supported by the fact that every year, we are getting fluorinated drugs in the market in extremely significant numbers. Last year, also ten fluorinated drugs have been approved by FDA and during the COVID-19 pandemic, fluorinated drugs played a very crucial role to control the disease and saved many lives.

Fluorinated Nucleosides: Synthesis, Modulation in Conformation and Therapeutic Application.

Over the last twenty years, fluorination on nucleoside has established itself as the most promising tool to use to get biologically active compounds that could sustain the clinical trial by affecting the pharmacodynamics and pharmacokinetic properties. Due to fluorine's inherent unique properties and its judicious introduction into the molecule, makes the corresponding nucleoside metabolically very stable, lipophilic, and opens a new site of intermolecular binding. Fluorination on various nucleosides has been extensively studied as a result, a series of fluorinated nucleosides come up for different therapeutic uses which are either approved by the FDA or under the advanced stage of the clinical trial.

-adenosyl-L-homocysteine Hydrolase: Its Inhibitory Activity Against and Development of Malaria Drugs.

Parasite Plasmodium falciparum is continuously giving a challenge to human beings by changing itself against most of the antimalarial drugs and its consequences can be seen in the form of a huge number of deaths each year especially in the poor and developing country. Due to its drug resistance ability, new drugs are regularly needed to kill the organism. Many new drugs have been developed based on different mechanisms.